Nuformix PLC Director/PDMR Dealings
November 05 2024 - 9:25AM
RNS Regulatory News
RNS Number : 0442L
Nuformix PLC
05 November 2024
5 November 2024
Nuformix
plc
("Nuformix" or the "Company" or the "Group")
Director/PDMR
Dealings
Nuformix plc (LSE:NFX), a
pharmaceutical development company targeting unmet medical needs in
fibrosis and oncology via drug repurposing,
announces further to the completion of the Placing and
Subscription to raise gross proceeds of £300,000, as announced on
20 September 2024, and Admission of the New Ordinary Shares today,
further details of the Directors' participation in the
Fundarise.
Each of the Company's Directors have
subscribed for the following New Ordinary Shares at the Issue
Price:
|
Name
|
Position
|
Ordinary shares subscribed for
|
%
held of enlarged share capital on Admission
|
|
Julian Gilbert
|
Non-Executive Chairman
|
22,000,000
|
1.57%
|
|
Maddy Kennedy
|
Non-Executive Director
|
22,000,000
|
1.57%
|
|
Dan Gooding
|
Executive Director
|
12,000,000
|
3.49%
|
The notifications below, made in
accordance with the requirements of the EU Market Abuse Regulation
(2014/596/EU) as it forms part of United Kingdom domestic law by
virtue of the European Union (Withdrawal) Act 2018 and as modified
by or under the European Union (Withdrawal) Act 2018 or other
domestic law, provides further detail.
Terms used in this announcement
shall, unless the context otherwise requires, be as defined in the
Prospectus published by the Company on 16 October 2024.
Enquiries:
|
Nuformix plc
|
|
|
Dr Dan Gooding, Executive
Director
|
Via IFC Advisory
|
|
CMC
Markets
|
|
|
Douglas Crippen
|
+44 (0) 20 3003 8632
|
|
|
|
|
IFC
Advisory Limited
|
|
|
Tim Metcalfe
Zach Cohen
|
+44 (0) 20 3934 6630
nuformix@investor-focus.co.uk
|
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a)
|
Name
|
Julian Gilbert
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-Executive Chairman
|
|
b)
|
Initial notification/ Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Nuformix plc
|
|
b)
|
LEI
|
2138003XG3H3I2J3BJ24
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary shares of nominal value
0.05 pence
GB00BYW79Y38
|
|
b)
|
Nature of the transaction
|
Purchase of ordinary
shares
|
|
c)
|
Price(s) and volume(s)
|
Price(s) Volume(s)
0.05 pence
22,000,000
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
22,000,000
£11,000
|
|
e)
|
Date of the transaction
|
5 November 2024
|
|
f)
|
Place of the transaction
|
Outside a trading venue
|
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a)
|
Name
|
Maddy Kennedy
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-Executive Director
|
|
b)
|
Initial notification/ Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Nuformix plc
|
|
b)
|
LEI
|
2138003XG3H3I2J3BJ24
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary shares of nominal value
0.05 pence
GB00BYW79Y38
|
|
b)
|
Nature of the transaction
|
Purchase of ordinary
shares
|
|
c)
|
Price(s) and volume(s)
|
Price(s) Volume(s)
0.05 pence
22,000,000
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
22,000,000
£11,000
|
|
e)
|
Date of the transaction
|
5 November 2024
|
|
f)
|
Place of the transaction
|
Outside a trading venue
|
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a)
|
Name
|
Dan Gooding
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Executive Director
|
|
b)
|
Initial notification/ Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Nuformix plc
|
|
b)
|
LEI
|
2138003XG3H3I2J3BJ24
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary shares of nominal value
0.05 pence
GB00BYW79Y38
|
|
b)
|
Nature of the transaction
|
Purchase of ordinary
shares
|
|
c)
|
Price(s) and volume(s)
|
Price(s) Volume(s)
0.05 pence
12,000,000
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
12,000,000
£6,000
|
|
e)
|
Date of the transaction
|
5 November 2024
|
|
f)
|
Place of the transaction
|
Outside a trading venue
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHFLFFSLSLEIIS
Nuformix (LSE:NFX)
Historical Stock Chart
From Nov 2024 to Dec 2024
Nuformix (LSE:NFX)
Historical Stock Chart
From Dec 2023 to Dec 2024
